Mechanistic insights into the inhibition of drug‐resistant cytomegalovirus by letermovir and ganciclovir
Despite different mechanisms of action, both drugs inhibited the spread of newly emerging resistant viruses around wild-type CMV-infected lesions during letermovir/ganciclovir treatment, suggesting the practical use of both drugs and strategies for treating drug-resistant CMV.
Authors
- Y Takemura (ORCID: https://orcid.org/0000-0002-4389-1400)
- Kaoru Sakai (ORCID: https://orcid.org/0000-0003-0803-0397)
- Tohru Daikoku
- Noriaki Sato
- Atsuko Shiraki (ORCID: https://orcid.org/0000-0002-6080-8082)
- Motoko Yanagita (ORCID: https://orcid.org/0000-0002-0339-9008)
- Kazunari Tanabe (ORCID: https://orcid.org/0000-0003-1775-547X)
- Kimiyasu Shiraki (ORCID: https://orcid.org/0000-0002-5218-4249)
- Seiya Imoto
- Masaya Takemoto
Institutions
- Senri Kinran University (JP)
- Kyoto University (JP)
- Hokuriku Electric Power Company (Japan) (JP)
- Toyama City Hospital (JP)
- Chiba-Nishi General Hospital (JP)
- Toyama University Hospital (JP)
- Shonan Kamakura General Hospital (JP)
- Hokuriku University (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1111/bph.70239
- Citations
- 1
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.35